Rescheduling should shift the conversation from debating cannabis’ medical value to exploring how patients can safely access it.
While rescheduling marks progress, rescheduling alone will not address the systemic challenges faced by patients or businesses in the current state of medical cannabis programs. Schedule III does not legalize medical cannabis, improve state medical cannabis programs, restore federal rights for patients, or create a pathway for complex botanicals to achieve the status of medicine.
Share this page
